Continuous glucose monitoring in acute ischemic stroke patients treated with endovascular therapy: A pilot study to assess feasibility and accuracy.

Autor: C J B A Kersten, A A M Zandbergen, M J Fokkert, R J Slingerland, H M den Hertog

Publikováno v: PLoS ONE, Vol 18, Iss 2, p e0280153 (2023)

IntroductionHyperglycemia is common in acute ischemic stroke and is associated with larger infarct volume and unfavorable functional outcome, also in patients who undergo reperfusion therapy. Hyperglycemia during reperfusion may be a therapeutic targ

Externí odkaz: https://doaj.org/article/4a92ff25d77544d0af373365081d9474

Effect of metformin on outcome after acute ischemic stroke in patients with type 2 diabetes mellitus

Autor: C J B A, Kersten, I L H, Knottnerus, E, Heijmans, M, Haalboom, A A M, Zandbergen, H M, den Hertog

Publikováno v: Journal of Stroke and Cerebrovascular Diseases, 31(9):106648. W.B. Saunders

Introduction: Diabetes mellitus is a well-known risk factor for ischemic stroke and is associated with unfavorable outcome after stroke. Metformin is recommended as first-line treatment in these patients. Pre-stroke metformin use might have neuroprot

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8249ab53653423842eb7396c694459b6
https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106648

Pituitary dysfunction and association with fatigue in stroke and other acute brain injury

Autor: M J M Pouwels, H M den Hertog, W D C Gaykema, Heleen A. Booij, K A J Kuijpers

Publikováno v: Endocrine Connections, Vol 7, Iss 6, Pp R223-R237 (2018)

Background Poststroke fatigue (PSF) is a highly prevalent and debilitating condition. However, the etiology remains incompletely understood. Literature suggests the co-prevalence of pituitary dysfunction (PD) with stroke, and the question raises whet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b72d394ea765b880778f95569fadcf6
http://www.endocrineconnections.com/content/7/6/R223.full

Increased admission and fasting glucose are associated with unfavorable short-term outcome after intra-arterial treatment of ischemic stroke in the MR CLEAN pretrial cohort

Autor: H. M. den Hertog, Elizabeth Osei, Adrienne A.M. Zandbergen, Debbie Beumer, Jelis Boiten, Yvo B.W.E.M. Roos, Puck S. S. Fransen, Diederik W.J. Dippel, Peter J. Koudstaal, Olvert A. Berkhemer, Wouter J. Schonewille, R. J. van Oostenbrugge

Publikováno v: Journal of the Neurological Sciences, 371, 1-5. Elsevier
Journal of the Neurological Sciences, 371, 1-5. Elsevier Science
Journal of the neurological sciences, 371, 1-5. Elsevier

Background Limited data are available on the impact of fasting glucose on outcome after intra-arterial treatment (IAT). We studied whether hyperglycemia on admission and impaired fasting glucose (IFG) are associated with unfavorable outcome after IAT

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6554648c0348e3261a6b03246f4e9fb
https://pure.eur.nl/en/publications/8983d257-171b-4aa4-981b-4b48a2f08b35

C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death

Autor: Peter J. Koudstaal, H. B. van der Worp, H. M. A. van Gemert, R. de Jonge, H. M. den Hertog, Diederik W.J. Dippel, J. A. van Rossum

Publikováno v: Journal of Neurology
Journal of Neurology, 256(12), 2003-2008. D. Steinkopff-Verlag

Acute ischemic stroke may trigger an inflammatory response that leads to increased levels of C-reactive protein (CRP). High levels of CRP may be associated with poor outcome because they reflect either an inflammatory reaction or tissue damage. We ev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98a02c240450cce8c7f71dc958ee9bc7
http://europepmc.org/articles/PMC2780652